Daixing Hu

840 citations
40 papers · 605 indexed · h-index 15
Topics
Thyroid Cancer Diagnosis and Treatment (17 papers)Thyroid and Parathyroid Surgery (11 papers)Cancer-related molecular mechanisms research (5 papers)
Partner nations
ChinaGermanySwitzerland

In The Last Decade

Daixing Hu

38 papers receiving 603 citations

Peers

Daixing Hu
Comparison fields: 5 of 69
  • Molecular Biology 250
  • Endocrinology, Diabetes and Metabolism 214
  • Pulmonary and Respiratory Medicine 182
  • Cancer Research 169
  • Surgery 151
Replace Chuanming Zheng with:
Chuanming Zheng China
Haoyu Ren China
Shangtong Lei China
Rong-Liang Shi China
Qingsi He China
Hyeong Ju Kwon South Korea
Ivan Marković Serbia
Helina Somervell United States
Xiabin Lan China
Deguang Kong China
Daixing Hu relative to Chuanming Zheng China Chuanming Zheng's profile →
Citations per field
00.5×1.7×
Chuanming Zheng · 1×
Citations per year

Countries citing papers authored by Daixing Hu

Since Specialization
Citations

This map shows the geographic impact of Daixing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daixing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daixing Hu more than expected).

Fields of papers citing papers by Daixing Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daixing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daixing Hu. The network helps show where Daixing Hu may publish in the future.

Co-authorship network of co-authors of Daixing Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Daixing Hu. A scholar is included among the top collaborators of Daixing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daixing Hu. Daixing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 4
4 3
5 6
6 3
7 14
8 2
9 9
10 21
11 17
12 11
13 8
14 5
15 28
16 18
17 43
18 74
19 11
20 39

About Daixing Hu

Daixing Hu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 605 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid and Parathyroid Surgery (11 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (214 citations), Cancer Research (169 citations) and Pulmonary and Respiratory Medicine (182 citations). Daixing Hu has collaborated with scholars based in China, Germany and Switzerland. Frequent co-authors include Jie Zhu, Xinliang Su, Wei Tang, Guozhi Zhao, Xin Zhao, Mi Zhou, Xin Zhu, Jiang Li, Haoyu Ren and Qi Xiao. Their work appears in journals such as Experimental Cell Research, Advanced Science and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026